Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction

Published:2006-02-20 Issue:2 Volume:8 Page:122-130
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Westendorp Bart¹,Schoemaker Regien G.¹²,Buikema Hendrik¹,Boomsma Frans³,van Veldhuisen Dirk J.²,van Gilst Wiek H.¹²

Affiliation:

1. Department of Clinical Pharmacology; University Medical Center Groningen; A. Deusinglaan 1, 9713 AV Groningen The Netherlands

2. Department of Cardiology; University Medical Center; Groningen The Netherlands

3. Department of Internal Medicine; Erasmus MC; Rotterdam the Netherlands

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Contemporary management of patients with left ventricular systolic dysfunction. Results from the study of patients intolerant of converting enzyme inhibitors (SPICE) registry;Bart;Eur Heart J,1999

2. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative trial;Granger;Lancet,2003

3. Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The captopril and thrombolysis study (CATS) investigators;Heuvel;J Am Coll Cardiol,1997

4. Beta-blocker withdrawal syndrome;Williams;Lancet,1979

5. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure;Thadani;Cardiovasc Drugs Ther,1997

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis;Internal Medicine;2021-02-15

2. COVID‐19 and renin‐angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) ‐ Is there any scientific evidence for controversy?;Journal of Internal Medicine;2020-06-08

3. Heart-Kidney Cross-Talk;Critical Care Nephrology;2019

4. Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study;European Journal of Preventive Cardiology;2016-07-10

5. Cardiorenal Syndrome Type 1;Journal of the American College of Cardiology;2012-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3